- Research article
- Open access
- Published:
The role of PB1-F2 in adaptation of high pathogenicity avian influenza virus H7N7 in chickens
Veterinary Research volume 55, Article number: 5 (2024)
Abstract
Avian influenza viruses (AIV) of the H7N7 subtype are enzootic in the wild bird reservoir in Europe, cause infections in poultry, and have sporadically infected humans. The non-structural protein PB1-F2 is encoded in a second open frame in the polymerase segment PB1 and its sequence varies with the host of origin. While mammalian isolates predominantly carry truncated forms, avian isolates typically express full-length PB1-F2. PB1-F2 is a virulence factor of influenza viruses in mammals. It modulates the host immune response, causing immunopathology and increases pro-inflammatory responses. The role of full-length PB1-F2 in IAV pathogenesis as well as its impact on virus adaptation and virulence in poultry remains enigmatic. Here, we characterised recombinant high pathogenicity AIV (HPAIV) H7N7 expressing or lacking PB1-F2 in vitro and in vivo in chickens. In vitro, full-length PB1-F2 modulated viability of infected chicken fibroblasts by limiting apoptosis. In chickens, PB1-F2 promoted gastrointestinal tropism, as demonstrated by enhanced viral replication in the gut and increased cloacal shedding. PB1-F2’s effects on cellular immunity however were marginal. Overall, chickens infected with full-length PB1-F2 virus survived for shorter periods, indicating that PB1-F2 is also a virulence factor in bird-adapted viruses.
Introduction
Influenza A viruses (IAV) are RNA viruses belonging to the Orthomyxoviridae family, which also comprises the genera Influenza B, C, and D [1]. While most Influenza viruses have a limited host range, IAV infect a wide spectrum of host species, including birds and mammals. Avian Influenza viruses (AIV) are prevalent in wild bird populations [2]. Aquatic birds are the natural reservoir and spread the virus globally along their migration routes [3]. AIV are divided according to variations of the surface glycoproteins, hemagglutinin (HA or H) and neuraminidase (NA or N), into 16 HA and 9 NA subtypes. While normally AIV exhibit low pathogenicity (LP) in poultry, LP H5/H7 subtypes can transform to high pathogenicity (HP) AIV and cause high and rapid mortality [4]. With the exception of the current panzootic H5Nx Goose/Guangdong lineage, HP H7 outbreaks are more prevalent than HP H5 outbreaks [5]. H7N9 is endemic in China since 2013 [6], and H7N3 is endemic in Mexico since 2012 [7, 8], in addition to several H7N7 outbreaks in Europe and Asia. H7 viruses show a broad species range and infect, besides wild and domestic birds, also harbour seals, horses, pigs, and humans [9]. The majority of human cases with confirmed IAV H7 infection present as mild or asymptomatic, yet several epidemics have demonstrated that such viruses are a non-negligible zoonotic threat, especially for those working closely with poultry [10,11,12].
AIV possess a segmented genome encoding several structural and non-structural proteins, including PB1-F2, which is expressed from an alternative open reading frame (ORF) of the polymerase segment PB1. Interestingly, PB1-F2 is only present in IAV, while Influenza B viruses do not express PB1-F2 [13]. It is a non-structural protein that is only detected in infected cells and has not yet been found in purified virions [14]. PB1-F2 is mostly 90 amino acids (aa) long, however, it can vary in length. Mutations result in the expression of truncated forms by either deleting the start codon [13] or by introducing premature stop codons at various position of the PB1-F2 ORF (e.g. positions 12, 25, 26, 38 and 58) [15]. Likewise, extended forms (up to 106 aa) have been reported [16]. The expression pattern of PB1-F2 is host-dependent. AIV typically carry the full-length protein [17], whereas PB1-F2 is under a strong negative selection pressure in mammal-adapted IAV [18]. The biological functions attributed to PB1-F2 expression are strain- and cell-specific. In mammalian hosts, full-length PB1-F2 has been associated with induction of apoptosis [13], increased polymerase activity [19], and enhanced virulence in mice [20], that causes increased vulnerability to bacterial superinfections [21]. It has been shown to interfere with interferon type I pathways [22, 23] and can stimulate immunopathology [24]. Despite the high prevalence of full-length PB1-F2 in AIV, its function in avian hosts is not fully understood. Some studies have shown that full-length PB1-F2 reduced virulence (H9N2 A/chicken/Pakistan/UDL01/08 [25], H5N1 A/duck/Niger/2090/2006 [26]), while others reported increased virulence (H5N1 A/Viet Nam/1203/2004 [27]) or no impact on disease outcome [28]. These inconsistent results suggest that the role of PB1-F2 in maintaining virus fitness depends heavily on virus subtype and experimental conditions. Most of these studies investigated H5 and H9 AIV, while data on the role of PB1-F2 in the fitness of H7 viruses is scarce. Considering the high prevalence of full-length PB1-F2 in potentially zoonotic AIV, there is an imminent risk of introduction into a vulnerable human population. A better understanding of the roles of this protein in the natural host could contribute to prevention of avian-to-human spill-over, particularly considering its potential role in viral shedding [26].
Here, we utilize HPAIV H7N7 expressing full-length (designated hereafter as wt) or lacking (designated hereafter as ΔF2) PB1-F2 to investigate the role of this non-structural protein in adaptation in vitro and in vivo. We hypothesize that full-length PB1-F2 may be evolutionary beneficial for IAV in avian hosts.
Materials and methods
Cells
MDCK-II (Madin-Darby canine kidney cells), HEK293T (human embryo kidney cells) and DF-1 (chicken fibroblasts) were sourced from the Collection of Cell Lines in Veterinary Medicine (CCLV) at the FLI. Chicken embryo kidney (CEK) cells were prepared as previously done [29]. Briefly, after incubating for 18–19 days at 37 °C chicken embryos were humanly killed, kidneys were harvested, cut, trypsinized and strained, producing a cell suspension.
The cells were cultivated using media also provided by CCLV: Confluent cells were treated with trypsin; detached cells were then resuspended in their respective media. A combination of MEM (Hank’s salts), MEM (Earle’s salts) and NEA were used for MDCK-II. DF-1 and HEK293T were cultivated in Ham’s F12 and IMDM (1:1). For all cells 10% fetal bovine serum (FBS) (PAN biotech) and 1% penicillin/streptomycin (100×) were added to the media. The cells were incubated at 37 °C and 5% CO2. CEK cells were seeded using MEM (Earle’s salts), 10% FBS, 1% P/S and 0.1% Amphotericin B in plates, that were previously treated with gelatine.
Viruses
All experiments were conducted with high pathogenicity (HP) H7N7 A/chicken/Germany/AR1385/2015. The virus was previously isolated and characterized by Dietze et al. [30]. The recombinant HP H7N7 viruses expressing full-length PB1-F2 (wt) as well as the respective plasmids were previously described [31]. The knockout virus (ΔF2) was created by introducing a point mutation (C138A) to PB1 using the QuikChange Site-directed mutagenesis kit (Invitrogen). This mutation was silent in the PB1 reading frame, but changed Serine to a stop codon and truncated PB1-F2 at 12 amino acids (aa) length as previously described by James et al. [25].
All recombinant viruses were rescued and propagated as previously described [32, 33]. Briefly, embryonated chicken eggs were inoculated with supernatant from a transfected co-culture of HEK293T and MDCK-II. Allantoic fluid was harvested and checked for bacterial contamination. Sequences were checked by Sanger sequencing and using Geneious software. All experiments with infectious virus were conducted under BSL3-conditions.
Polymerase assay
We investigated the mutation’s impact on the polymerase activity with a luciferase based minigenome assay as previously done [34]. Briefly, sub-confluent HEK293T cells were subjected to Lipofectamine 2000 based transfection of pHW plasmids containing the segments of the polymerase complex (polymerase basic protein 1 and 2 (PB1, PB2), polymerase acidic protein (PA) and nucleoprotein (NP)) as well H7-Nanoluciferase (NanoLuc) and Firefly-Luciferase. The latter was added as a transfection control. As negative control, the empty pHW vector was transfected instead of PB2. 48 h post-transfection cells were harvested using 2 × Lysis-Juice (PJK) and water 1:1. To enhance the signals, samples were frozen at −20 °C for at least 30 min. Subsequently, Firefly and NanoLuc reagent was added to the rethawed samples. Luminescence was detected with a GloMax® Discover Microplate Reader. The NanoLuc expression was normalized against Firefly expression. Several attempts to transfect DF1 cells were not satisfactory due to the high background noise, therefore, we used standard HEK293 cells.
Viral replication kinetics
The respective cells (CEK, DF-1, MDCK-II) were inoculated with virus suspension containing a multiplicity of infection (MOI) of 0.001. After 1 h of incubation at 37 °C, 5% CO2 the supernatant was removed. On MDCK-II and CEK cells all non-intracellular virus was inactivated using citric acid buffer (CBS, pH = 3.0). After washing thrice with PBS, MEM containing bovine serum albumin (BSA) was added. DF-1 cells detached after CBS treatment, therefore the extracellular virus was removed only by several washing steps with PBS. Subsequently, media consisting of MEM (Hank’s salts), MEM (Earle’s salts), NEA and 0.56% BSA solution (35%) was added. The cells were incubated at 37 °C. At the respective time points (1, 8, 24 and 48 h post-infection (hpi)) cells were collected using a cell scraper and immediately frozen at −70 °C for later titration.
Virus titration
For virus titration confluent MDCK-II cells were infected in ten-fold dilutions with 250 µL viral suspension from either replication kinetics or swab samples. After incubation (1 h, 37 °C) and washing plaque test media containing Bacto-Agar was added. For titration of swab samples, medium containing 1% Penicillin/Streptomycin to counteract bacterial infections was used. Four days post-infection (dpi) the cells were fixed by applying crystal violet in formalin (0.1%) for 24 h. Subsequently the staining solution as well as the agarose was removed. Dried plates were counted and titres were calculated: Plaque forming units (PFU)/mL = PFU × dilution factor.
Plaque size assay
To investigate cell-to-cell spread we infected confluent MDCK-II cells and subsequently, a standard plaque test (see above) was performed. After fixation, the cells were stained a second time. A total of 55 PFU (wt), and 87 PFU (ΔF2) were counted using a Nikon eclipse Ti as well as the corresponding software’s 3-point measurement option (NIS Elements BR).
Flow cytometrical analysis of DF-1 cells
Confluent DF-1 cells were infected at MOI 0.1. After incubation (1 h, 37 °C, 5% CO2) the cells were washed once with PBS. MEM containing BSA was added, subsequently. 24 hpi the cells were trypsinized, washed and resuspended (PBS). Staining against surface antigens was performed in various 20 min intervals including washing steps with Cell staining buffer (PBS with 0.1% FBS, 0.4% Natrium acid (25% solution)). The cells were fixed and permeabilized with intracellular staining buffer (Biolegend) according to the manufacturer’s instructions. Subsequently, intracellular staining was performed.
Antibodies against surface antigens were diluted in Cell staining buffer, those against intracellular antigens in PermWash (Biolegend). Measurement was performed using the BD LSRFortessa™ Cell analyzer. Compensation and interpretation were done using BD FACSDIVA™ software.
Animals and eggs
SPF chicken eggs used for virus isolation and propagation and animal experiment were sourced from Valo BioMedia (VALO SPF chickens). Eggs used in in vivo studies were hatched at FLI, Celle. Day old chicks were transferred to and raised at the animal facilities at FLI, Riems in a barn system. They were fed with commercial chicken feed (Panto KAK 2 mm).
Antibodies
Primary antibodies
All primary antibodies are indicated in Table 1 (Primary antibodies used for multiparametric staining for flow cytometry).
Secondary antibodies
All secondary antibodies are indicated in Table 2 (Secondary antibodies used for multiparametric staining for flow cytometry).
Chicken experiment
All experiments were performed in accordance with the German regulations for animal welfare. The authorized ethics committee of the State Office of Agriculture, Food Safety and Fishery in Mecklenburg-Western Pomerania approved the conduction of the animal experiment (file no. 7221.3–1-060/17). Furthermore, the in vivo studies had the approval of the commissioner for animal welfare at the FLI, representing the Institutional Animal Care and Use Committee (IACUC).
Ten 7-week-old chickens per group were infected oculonasally with 200 µL of virus solution containing 105 PFU/mL of the respective virus (wt or ΔF2) per animal. 24 hpi contact birds (n = 5) were introduced. Four dpi 3 animals per group were sacrificed for necropsy, organ samples were stored both in formaldehyde (histopathology) and at −70 °C.
Swab samples were collected from the oropharynx and cloaca, shaken and then stored at −70 °C respectively, in 1 mL swab sample medium (cell culture media containing 1% Enrofloxacin, 0.5% Lincomycin and 0.1% Gentamicin) at 1, 2, 3, 4, 7 and 10 dpi. To analyse the cellular immune response blood was collected at 1, 2, 4 and 7 dpi from 6 animals per group. If less than six birds, that were originally infected, survived, the number of samples was reduced accordingly. Contact birds were not considered for blood drawing.
The animals were scored daily as previously done [31]. Clinical signs were scored from 0 to 3. “0” represents a healthy animal, “1” is an animal with mild disease, exhibiting only one symptom. Animals with severe disease and/or multiple symptoms are scored as “2”, dead animals as “3”. Chickens, that were unable to move, feed or hydrate adequately and independently, were euthanized and scored as “3” the following day. Surviving chickens were euthanized 10 dpi using Isoflurane CP® (CP pharma). Blood was drawn and plasma collected to test for seroconversion.
Blood processing and staining for flow cytometry
Approximately 0.5 mL of blood were taken per chicken in lithium-heparin vials. After collecting and storing of plasma at −70 °C, the remaining blood cells were resuspended in PBS up to the original volume and then subjected to density centrifugation (900 × g, 30 min, without break) over a FICOLL-gradient. The buffy coat was collected, washed once and resuspended in PBS.
The isolated chicken PBMCs were divided and subsequently stained following a T cell panel or staining for antigen presenting cells. Between each staining step, cells were washed with Cell staining buffer. After the extracellular staining was complete the cells were fixed using Fixation buffer (BioLegend) according to the manufacturer’s protocol. The samples were measured using the BD LSRFortessa™ Cell analyzer. Compensation and interpretation were done using BD FACSDIVA™ software.
Seroconversion
To determine seroconversion collected plasma was inactivated (56 °C, 120 min) and then tested for AIV nucleoprotein (NP) antibodies using commercially available enzyme-linked immunosorbent assay (ELISA) according to the manufacturer’s instructions (ID screen Influenza A Antibody Competition Multispecies kit, IDvet). Optical density (OD) was measured in a Tecan® ELISA reader. In compliance with the manufacturer’s guidelines the cut-off point was 55%, samples lower than 45% were considered negative. Samples between 45 and 55% were considered as questionable.
RNA extraction
100 mg per thawed organ sample was subjected to RNA extraction. After adding one steel bead (5 mm) and 1 mL Trizol per sample, the organs were homogenized in a Tissue Lyser II (Qiagen). Subsequently, RNA was extracted using the RNeasy kit (Qiagen) and stored at −70 °C.
Virus load in organs
The viral copy numbers in organ samples were determined by generic matrix protein 1 (M1) real-time reverse-transcription PCR (RT-qPCR) using the SuperScript™ III One-Step RT-PCR System with Platinum™ Taq DNA Polymerase. Standard curves of H7N7 were included in the run, allowing the calculation of virus content in PFU/g equivalents by plotting the Ct-values of the standard curves. The utilized primers are supplied in Table 3 (Primers for M1 real-time RT-qPCR) and have been previously published [35].
Histopathological and immunohistochemical examination
Full autopsy was performed on all animals under BSL3 conditions. Samples from skin (wattle), nasal conchae, lung, heart, liver, pancreas, duodenum, cecum, brain, spleen, cecal tonsil, thymus, and bursa of Fabricius, of three birds at 4 dpi were fixed in 10% neutral buffered formalin. Tissues were paraffin-embedded and 2–3-μm-thick sections were stained with haematoxylin and eosin (HE). Immunohistochemistry (IHC) was performed for viral antigen detection using a primary antibody against the matrix (M1) protein of IAV (ATCC clone HB-64), the avidin and biotinylated enzyme (ABC) method, AEC (3-Amino-9-Ethylcarbazole) chromogen (red), and haematoxylin (blue) counterstain as described earlier [36]. Stained tissue slides were scanned using Hamamatsu S60 scanner and evaluated using NDPview.2 plus software (Version 2.8.24, Hamamatsu Photonics, K.K. Japan). Evaluation and interpretation were performed by a board-certified pathologist (AB, DiplECVP) in a blinded fashion. Archived tissue section from age-matched, non-infected chicken were included for comparison as controls. The severity of necrotizing inflammation was evaluated for the skin, nasal conchae, lung, heart, liver, pancreas, duodenum, cecum, brain. Additionally, for the brain, the area affected by perivascular inflammatory infiltrates and microglial cell nodules was recorded. The lesions and distribution of virus antigen was graded on an ordinal scale with scores 0 = no lesion/antigen, 1 = focal/rare, affected cells/tissue < 5% or up to 3 foci per tissue; 2 = multifocal, 6%–40% affected; 3 = coalescing, 41%–80% affected; 4 = diffuse, > 80% affected. To assess a possible induction of apoptosis we graded (i) the lymphocyte cellularity for the thymus, spleen, cecal tonsil and bursa; and (ii) the occurrence of tingible body macrophages (TBM, macrophages containing phagocytized, apoptotic cells) for the thymus. Decreased lymphocyte cellularity, increased TBM numbers was scored 0 = not present, 1 = minimal, 2 = mild, 3 = moderate, 4 = severe.
Statistics
Statistical analyses were performed using GraphPad Prism 9. Data was tested for normality (Shapiro–Wilk test and Kolmogorov–Smirnov-test). Based on this, appropriate statistical tests were selected: For polymerase activity and DF-1 phenotype One-Way ANOVA was chosen. Data concerning replication kinetics, DF-1 phenotype at multiple MOI, clinical scoring, virus shedding, and cellular immunity were analysed by two-way ANOVA. Cell-to-cell-spread was calculated by Mann Whitney test. Survival rates were plotted as Kaplan Meier curves with Log-rank (Mantel-Cox) test. Significant differences were depicted according to the P-value as non-significant (ns) (P > 0.05), * (P ≤ 0.05), ** (P ≤ 0.01), *** (P ≤ 0.001), **** (P ≤ 0.0001).
Results
Deletion of PB1-F2 accelerates viral replication at early time points
We constructed two recombinant viruses based on A/chicken/Germany/AR1385/2015 (AR1385). This virus was isolated in 2015 from a limited outbreak in flocks of laying hens in Emsland, Germany [30]. Both wt and ΔF2 (Figure 1A) viruses replicated to similar titres (1–2 × 105 plague forming units (PFU)/mL viral stock) in embryonated chicken eggs. Sequencing of stock viruses (HA, NA, PB1) revealed no off-target mutations.
The IAV polymerase complex is composed of four subunits (PB2, PB1, PA, and NP). These segments make up the minireplicon of viral RNA transcription and replication and can be analysed in a transfection-based polymerase activity assay. To investigate whether the introduced mutation in PB1-F2, which is encoded on the PB1 segment, affects overall polymerase activity we conducted minigenome reporter assays. After transfection of HEK293T cells with the aforementioned minireplicon segments as well as H7-Nanoluciferase (NanoLuc) and Firefly-Luciferase, NanoLuc luminescence was measured and normalized to the luminescence of the transfection control (Firefly Luciferase). Both wt and ΔF2 were able to replicate the luciferase reporter genome as was demonstrated when compared to the control, which lacked the PB2 component of the viral polymerase (Figure 1B). However, while the results of ΔF2 varied more than those of wt, no significant impact on the polymerase activity was observed.
To assess viral fitness, we performed viral replication kinetics in an avian (chicken fibroblasts (DF-1)) cell line, primary chicken embryo kidney cells (CEK), and a permissive mammalian cell line (Madin-Darby canine kidney cells type-II (MDCK-II)) (Figure 1C). ΔF2 replicated significantly better than wt 24 h post-infection (hpi) in DF-1 (4.1 × better) and MDCK-II cells (6.4 × better). However, this effect was compensated (DF-1) or reversed (MDCK-II) 48 hpi. In the latter, wt grew to significantly higher titres than ΔF2 (5.3 × higher). However, since the difference is less than one log-fold it is questionable whether these effects are of biological relevance. In all cells there was a trend, although not significant, for faster replication of ΔF2 8 hpi. To study the effect of PB1-F2 on cell-to-cell spread, we measured plaque diameters induced by wt and ΔF2 (Figure 1D). In this study, the average plaques formed after ΔF2 inoculation were found to be 14.7 µm larger in diameter compared to the wt plaques. Consequently, the knockout of PB1-F2 resulted in a more efficient establishment of infection in neighbouring MDCK-II cells. It is important to note, however, that the knockout virus again exhibited a higher degree of variability.
PB1-F2 limits apoptosis in infected cells
To investigate effects of AIV full length PB1-F2 on cellular viability, we employed flow cytometry. First, we established the infection dose in titration experiments with DF-1 cells using multiplicities of infection (MOI) of 0.1, 0.01, and 0.001 and collecting the cells for staining 24 hpi (Additional file 1). Applying MOI 0.1, a large population of infected IAV nucleoprotein (NP)-positive cells were detected (wt: 35.9% of live cells) and viability was only slightly reduced (wt: 72.7% of total cells). Therefore, all following flow cytometry experiments were conducted at MOI 0.1. When repeating our experiments to include staining for apoptotic cells (Additional file 2), we reached even higher infection rates (wt: 89.8%, ΔF2: 96.2%), while the differences between both viruses remained significant. Contrary to pro-apoptotic effects reported for full-length PB1-F2 [13, 37], we observed that PB1-F2 appeared to restrict cell death in avian cells. While 73% of the harvested cells survived wt infection, only 49% of ΔF2-infected cells were viable 24 hpi (Figure 2A). Considering the viral replication kinetics (Figure 1C), we assume that the early differences in viral titres resulted from variations in cell viability. However, the compensation or reversal in replication patterns observed 48 hpi might have been caused by different survival rates of infected cells.
We examined the infection status of the viable cells by staining for the viral NP and found wt infected 89.8% of cells, while ΔF2 was able to infect significantly more cells (96.2%) (Figure 2B). In addition, the mean fluorescent intensity for each NP-positive cell was measured and cells infected with ΔF2 had a 1.8 × higher intensity compared to wt, suggesting that upon infection more NP was present in cells infected by ΔF2 virus. Thus, PB1-F2 deletion spiked infection rates and also resulted in significantly increased synthesis of certain viral proteins (NP) in infected cells.
To evaluate whether the difference in viability was due to variability in apoptosis, we identified apoptotic cells by staining for active Caspase 3 (aCas3, Figure 2C). Both viruses caused significant apoptosis compared to the naïve control. In accordance with the live-dead staining, ΔF2 caused heightened apoptosis of infected cells (ΔF2: 22.5% vs. wt: 12.4%). Our data show that while infection generally triggers apoptosis in chicken cells, full length H7N7 PB1-F2, unlike the full-length versions carried by some mammal-adapted IAV [24], restricts apoptosis to a certain extent.
Truncation of PB1-F2 increases survival in chickens
To study the impact of PB1-F2 length on virus fitness in chickens, we inoculated chickens via the oculonasal route. To investigate the virus transmission, we introduced sentinels to the inoculated chickens 1 dpi. All chickens were observed daily and the pathogenicity index (PI) was calculated as previously done [31]. After infection with either wt or ΔF2, all inoculated chickens showed severe signs of disease. All wt-infected chickens and their cohoused chickens died, while 5 of 7 ΔF2-infected and 4 of 5 contact birds died (Figures 3A and B). The PI for wt- and ΔF2-inoculated chickens was 2.0 and 1.6, respectively. The viability pattern is also reflected in the clinical scoring: the survivors (ΔF2 animals #6, #9 and #13) showed signs of disease but recovered from infection (Figure 3D). Overall, both groups started to show symptoms at similar time points, however clinical disease progressed faster in wt-infected chickens (Figure 3C) than in those inoculated with the knockout virus (Figure 3D). Even though not statistically significant, this trend is also evident when directly comparing the groups (Figure 3E). The signs of disease varied depending on the virus: wt caused severe diarrhoea, whereas ΔF2 caused neurological symptoms (headshaking, dyscoordination) in approximately 50% of the infected birds. The mentioned neurological symptoms were detected at late stages of the infection (5 dpi and later). A significant decrease of the survival rate in both inoculated (Figure 3A) and contact birds (Figure 3B) was observed when full-length PB1-F2 was expressed (wt). The medium time to death was 5.7 dpi for wt-infected chicken and 6.2 dpi for ΔF2-infected chickens.
Subsequently, we performed a NP antibody competition ELISA using plasma collected from the surviving chickens 10 dpi. All survivors seroconverted, confirming that they were indeed infected with the virus. Thus, deletion of PB1-F2 does increase chances of survival after successful infection with HPAIV H7N7.
PB1-F2 enhances gastrointestinal shedding and viral replication in the gut
During the animal experiment, we collected oropharyngeal and cloacal swab samples to determine viral shedding 1, 2, 3, and 4 dpi. Titration by plaque assay revealed no significant difference between the two groups and timepoints in shedding from the oropharyngeal cavity (Figure 4A). The cloacal shedding, however, was significantly impacted by expression of PB1-F2. 4 dpi wt-infected chickens on average shed 102.63 plaque forming units per mL (PFU/mL), compared to ΔF2’s 101.88 PFU/mL. While 1 dpi swab samples showed no difference with respect to cloacal shedding, samples collected 2 dpi were indicative of cloacal shedding in wt-infected chickens: wt 102.44 PFU/ml vs. ΔF2 101.18 PFU/mL. In line with these observations, viral antigen detection in the intestine was restricted to wt-infected chicken (Figures 4D–F). We confirmed that infection with wt virus resulted in more abundant M1 copy number in the jejunum (Figure 4C). This was in line with reported gastrointestinal symptoms in wt-infected chickens.
PB1-F2 has no effect on systemic tissue tropism and morphological lesion development but may influence the death of immune cells in vivo
Supporting the data on PB1-F2-mediated enhanced gastrointestinal shedding, presence of viral antigen detection in the intestine was restricted to wt-infected chicken (Figures 4D–F). However, no significant difference was found for the remaining tissues tested, including the brain, the respiratory tract, heart, pancreas, liver, kidney, skin, and immune organs. Both, ΔF2 and wt infection led to high virus antigen scores in the brain, respiratory tract, skin, and immune organs. Both viruses exhibited endotheliotropism (Figure 5A). Target cells included the glandular and respiratory epithelium in the nasal mucosa, neurons, glial cells, and ependymal cells in the brain, air capillary cells in the lung, cardiomyocytes in the heart, acinar cells in the pancreas, sinusoid lining cells in the liver, tubular epithelium in the kidney, epidermal and mesenchymal cells (not specified) in the skin, as well as immune and mesenchymal cells in immune organs (Figures 5B–G). Of note, the endotheliotropism was particularly prominent in the dermis (wattle, Figure 5D) and mucosa of the nasal conchae.
Histopathology did not identify significant differences between chickens after wt or ΔF2 infection (Figure 6A). For both groups, a necrotizing inflammation was found in the brain, skin, nasal conchae and lungs. The detailed analysis of immune tissues yielded particularly high lesion scores for ΔF2-infected chickens in the thymus, showing decreased lymphocyte cellularity and increased tingible body macrophages (TBM) numbers and lymphocyte apoptosis/necrosis but not in the spleen and bursa (Figures 6B–K).
PB1-F2 marginally influences dynamics of blood immune cells
Since the impact of PB1-F2 on virulence could be caused by immune-driven inflammation, we analysed blood-derived T-lymphocytes (Figures 7A–F) and antigen-presenting cells (Figures 7G–H) by multiparametric flow cytometry. We observed few significant differences between wt- and ΔF2-infected chickens: 1 dpi animals inoculated with ΔF2 showed lower frequencies of γδ T lymphocytes (Figure 7A, wt: 27.7% vs. ΔF2: 12.9%)), which have features of both innate and adaptive immunity [38]. Nevertheless, the activation status of γδ T cells, detected by expression of CD8, was not affected compared to the naïve control (Figure 7B). Additionally, both viruses caused a lower frequencies of T effector cells 1 dpi (Figure 7C) and an increase in activated T helper cells (Figure 7F) 4 dpi compared to the naïve control group.
Furthermore, the percentage of monocytes (KUL-01 + MHCII + antigen presenting cells) was elevated in wt-infected chicken 2 dpi (20.7%) compared to ΔF2-infected chickens (7.7%). However, these monocyte frequencies were similarly low in both groups 4 dpi (wt: 5.1%, ΔF2: 3.0% vs. naïve control: 20.1%). Overall, the observed effects were only temporary.
Discussion
The aim of this study was to provide information on the relevance of PB1-F2 after infection of chickens with H7 IAV. Data on the effects of PB1-F2 in avian hosts are limited and contradictory.
Our studies showed that the PB1-F2 knockout enhanced viral replication in vitro accompanied by increased infection rates and synthesis of viral proteins, as well as ameliorated cell-to-cell spread. Potentially, due to antagonistic interaction with the cellular antiviral mechanisms [23], 48 hpi the replication advantage was either compensated or completely reversed, presumably due to increased survival rates of wt-infected cells, allowing efficient replication. However, due to the transiency of effects and the low log-fold difference, the biological impact might be limited. By contrast, expression of PB1-F2 is largely described to not influence viral titres in vitro (H9N2 A/chicken/Pakistan/UDL01/08 (UDL01) [25], PR8 [19]), though it should be noted that different MOIs were used (0.0001 [25] or 1 [19]). However, PB1-F2-containing H1N1 strains (PR8, A/Beijing/11/56 PB1-F2, and A/Brevig Mission/1/18 PB1-F2 in PR8 backbone) were reported to replicate to higher titres than the viruses lacking full-length PB1-F2 in a dose-dependent manner [39]. Consistent with our data, viruses replicating to higher titres also formed larger plaques and this effect was also exclusively present at early time points. [39]. This suggests that full-length PB1-F2 of mammalian- and avian-adapted viruses have opposing effects on viral replication.
Since survival of infected cells contributes to efficient viral replication, we investigated the viability of infected DF-1 cells. Surprisingly, we found that expression of full-length PB1-F2 increased the survival rate of infected chicken fibroblasts by limiting apoptosis. In contrast, PB1-F2 is largely considered to be pro-apoptotic in mammalian cells but its effects vary depending on virus strain and mammalian host cell. Indeed, LPAIV H6N1 (A/turkey/England/198/09), LPAIV H2N3 (A/mallard duck/England/7277/06) and recombinant HPAIV H5N1 demonstrated pro-apoptotic function in infected porcine macrophages, while several H1N1 viruses showed no effect in the same experimental setting [37]. Furthermore, PR8 PB1-F2 is pro-apoptotic [24, 40], whereas reports on PB1-F2 of 1918 H1N1 are diverse: PB1-F2 of A/Brevig Mission/1/18 in a PR8 backbone did not enhance apoptosis [24], while using the same ORF in the backbone of USSR/90/77 increased apoptosis compared to a knockout variant in murine macrophages [41]. HPAIV H7N7 do not share cytotoxic motifs (I68, L69, V70) previously described for PB1-F2 (Additional files 3, 4, 5) [42], which could be one reason why apoptotic degradation was limited. However, since all previous data was gathered from mammalian cell culture systems, it is plausible to consider that the restriction of apoptosis, despite the high conservation rate of apoptotic pathways [43], may be an exclusive feature of avian cells.
To investigate the recombinant H7N7 viruses in a complex organism and to explore potential tissue tropism and effects on cellular immunity, we infected White Leghorn SPF chickens. Interestingly, the truncation of PB1-F2 increased chances of survival of both inoculated and cohoused birds. While there were no differences in infection rates and disease onset, the ΔF2-infected chickens showed slower disease progression and some even recovered. Opposing effects were described for chickens infected with HPAI H5N1 (A/duck/Niger/2090/2006 (Nig06)) [26] and LPAIV H9N2 (A/chicken/Pakistan/UDL01/08) [25].
In other avian species the effect of PB1-F2 appears to be similarly variable: Swine influenza virus H3N2 (A/swine/Minnesota/1145/2007) lacking PB1-F2 infected turkeys more efficiently than its full-length counterparts [44]. However, while chickens and turkeys are both susceptible to AIV infection [45,46,47], it is not reasonable to expect swine-adapted and avian-adapted viruses to cause similar effects. Only the inoculation of ducks with HPAI H5N1 (VN/1203/04) generated results consistent with our obtained data: Animals infected with the knockout virus showed delayed onset of clinical disease and systemic spread of the virus [27]. In summary, the effect of PB1-F2 on the survival of infected birds depends on many variables.
Furthermore, our experiments showed that H7N7 HPAIV PB1-F2 promoted cloacal shedding, while its influence on oropharyngeal shedding was negligible. Conversely, LPAIV H9N2 prolongs buccal shedding [25]. Increased faecal virus shedding was associated with severe diarrhoea in wt-infected chickens, whereas ΔF2-infected chickens showed mainly neurological symptoms. Fittingly, the gastrointestinal symptoms were associated with increased viral copy numbers in the gut. The increased cloacal shedding as well as the gastrointestinal symptoms indicate that PB1-F2 facilitates gastrointestinal tissue tropism [48]. Immunohistochemistry supported this, as only wt-infected chickens showed viral antigen in the intestine, highlighting the severe viral burden in gastrointestinal tissues. However, histopathology did not reveal any lesions in the evaluated intestinal tissues (duodenum, cecum) to support the diarrhoea reported in wt-infected chickens. It cannot be excluded that lesions could have been detected in non-examined intestinal segments. While both viruses caused lesions of the central nervous system, the differences in clinical reaction might be due to different localizations, potentially caused by the deletion of PB1-F2.
Chickens of similar age inoculated with H5N1 (Nig06) virus showed similar viral shedding patterns: The group inoculated with Nig06 expressing PB1-F2 exhibited significantly higher viral copy numbers in the intestine and pancreas compared to the ΔF2 group [26].
Strikingly full-length PB1-F2 is conserved among many avian IAV isolates, however its prevalence varies depending on avian order. While only 87% of isolates from Galliformes carry full-length PB1-F2, isolates from Anseriformes (waterfowl) and Charadriiformes (waders, gulls, auks) express a complete PB1-F2 ORF at 97% and 98%, respectively [25]. This suggests that while full-length PB1-F2 is advantageous to chicken-adapted virus, it is even more crucial for viruses in the natural reservoir of waterfowl and shore birds. This might be explained by different modes of transmission, as AIV in wild aquatic birds replicate primarily in the gut and are excreted at high doses into the environment. Contact with contaminated surface water, either directly or indirectly, provides the main source of infection to susceptible waterfowl [3]. We hypothesize, that PB1-F2 ensures effective viral spread by causing gastrointestinal tropism in the natural reservoirs, explaining its high prevalence in these orders, specifically.
In addition, histopathology identified decreased lymphocyte cellularity in the thymus. Particularly high scores in the thymus were found after ΔF2 virus infection, accompanied by increased numbers of TBM containing phagocytized, apoptotic cells [49]. Increased lymphocyte apoptosis may result from direct thymic immunomodulatory effects or stress (e.g. disease-related decreased food intake, glucocorticoid release) [50]. Severe ongoing apoptosis results in greatly reduced lymphocyte cellularity. Increased TBM and decreased cellularity in the thymus but also in other immune organs may thus be a direct effect of immunomodulation or a secondary effect of stress. Either PB1-F2 or lack thereof [24] or death ligands (e.g. TNF, FasL or TRAIL), secreted due to severe inflammation [51], could contribute to apoptotic cell death.
We suggest that the immunomodulatory effect is directly virus-related. Our in vitro data demonstrated that both viruses caused apoptosis. While ΔF2 infection yielded more apoptotic DF-1 cells at the same infectious dose in vitro, the clinical data 4 dpi showed higher clinical scores for wt-infected birds compared to ΔF2-infected animals. Therefore, a higher level of disease-associated stress is to be expected in the wt-infected group, which in turn may outweigh ΔF2’s superior pro-apoptotic function.
The comparative data available was obtained in mammals. Here, the virulence of PB1-F2 containing viruses is partly attributed to its immunopathogenic effects: 1918 PB1-F2 in a PR8 backbone increased the cellularity of murine bronchoalveolar lavage fluid by an influx of T lymphocytes, macrophages, and neutrophils. This induced severe lung inflammation and lesions [24, 52], that in turn cause increased susceptibility to bacterial superinfections [21, 52]. Furthermore, PB1-F2 was shown to reduce the adaptive immune response due to its apoptotic properties, both directly, by causing apoptosis of T cells [53], as well as indirectly by decreasing antigen presentation by eliminating antigen presenting cells [13]. Surprisingly, HPAIV H7N7 PB1-F2 only marginally affected cellular immunity. We reported a significant reduction of γδ T lymphocytes in ΔF2-inoculated chickens 1 dpi. In mammals, they were reported to recognize antigens independently of MHC-II [38], and have antiviral properties [54]. In chickens, both effector and regulatory functions have been described [55,56,57]. Given the importance of γδ T cells at early stages of infection, it is likely that ΔF2 induces recruitment of γδ T cells into tissues. Additionally, wt-infected animals showed elevated monocyte levels 2 dpi. Overall, all reported effects were transient and had no discernible clinical impact.
It should be noted that our results showed a wide statistical spread. The reasons for this are twofold: firstly, genetic variance of the animals has an impact. Secondly, there were individual differences in disease onset and progression, which in turn caused variation in leukocyte levels and distribution. Furthermore, since HPAIV H7N7 induced severe disease in all infected animals, it is reasonable to assume, that disease progression in both wt and ΔF2 was too fast and grave to allow for distinct immunological profiles.
In conclusion, HPAIV H7N7 PB1-F2 facilitates viral adaptation in vitro by limiting apoptosis of infected chicken fibroblasts. Apart from replication deficits at early time points in vitro, we found no adverse effects of PB1-F2 in vitro. The virus expressing full-length PB1-F2 was more virulent and showed enhanced cloacal shedding and gastrointestinal tropism. Therefore, we propose that PB1-F2 is a virulence factor in chickens, that ensures effective viral spread.
References
Krammer F, Smith GJD, Fouchier RAM, Peiris M, Kedzierska K, Doherty PC, Palese P, Shaw ML, Treanor J, Webster RG, Garcia-Sastre A (2018) Influenza. Nat Rev Dis Primers 4:3
European Food Safety A, Aznar I, Baldinelli F, Stoicescu A, Kohnle L (2022) Annual report on surveillance for avian influenza in poultry and wild birds in Member States of the European Union in 2021. EFSA J 20:e07554
Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y (1992) Evolution and ecology of influenza A viruses. Microbiol Rev 56:152–179
Sutton TC (2018) The pandemic threat of emerging H5 and H7 avian influenza viruses. Viruses 10:461
de Bruin ACM, Funk M, Spronken MI, Gultyaev AP, Fouchier RAM, Richard M (2022) Hemagglutinin subtype specificity and mechanisms of highly pathogenic avian influenza virus genesis. Viruses 14:1566
He D, Gu M, Wang X, Yan Y, Li Y, Wang X, Hu S, Liu X (2023) Reintroduction of highly pathogenic avian influenza A H7N9 virus in southwestern China. Virus Genes 59:479–483
Navarro-Lopez R, Xu W, Gomez-Romero N, Velazquez-Salinas L, Berhane Y (2022) Phylogenetic inference of the 2022 highly pathogenic H7N3 avian influenza outbreak in Northern Mexico. Pathogens 11:1284
Youk S, Lee DH, Ferreira HL, Afonso CL, Absalon AE, Swayne DE, Suarez DL, Pantin-Jackwood MJ (2019) Rapid evolution of Mexican H7N3 highly pathogenic avian influenza viruses in poultry. PLoS One 14:e0222457
Abdelwhab EM, Veits J, Mettenleiter TC (2014) Prevalence and control of H7 avian influenza viruses in birds and humans. Epidemiol Infect 142:896–920
Wong SS, Yuen KY (2006) Avian influenza virus infections in humans. Chest 129:156–168
Bosman A, Meijer A, Koopmans M (2005) Final analysis of Netherlands avian influenza outbreaks reveals much higher levels of transmission to humans than previously thought. Euro Surveill 10(E050106):2
Shi J, Zeng X, Cui P, Yan C, Chen H (2023) Alarming situation of emerging H5 and H7 avian influenza and effective control strategies. Emerg Microbes Infect 12:2155072
Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, Basta S, O’Neill R, Schickli J, Palese P, Henklein P, Bennink JR, Yewdell JW (2001) A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7:1306–1312
Krumbholz A, Philipps A, Oehring H, Schwarzer K, Eitner A, Wutzler P, Zell R (2011) Current knowledge on PB1-F2 of influenza A viruses. Med Microbiol Immunol 200:69–75
Kamal RP, Alymova IV, York IA (2017) Evolution and virulence of influenza A virus protein PB1-F2. Int J Mol Sci 19:96
DeLuca DS, Keskin DB, Zhang GL, Reinherz EL, Brusic V (2011) PB1-F2 Finder: scanning influenza sequences for PB1-F2 encoding RNA segments. BMC Bioinformatics 12(Suppl 13):S6
Kamal RP, Kumar A, Davis CT, Tzeng WP, Nguyen T, Donis RO, Katz JM, York IA (2015) Emergence of highly pathogenic avian influenza A(H5N1) virus PB1-F2 variants and their virulence in BALB/c mice. J Virol 89:5835–5846
Zell R, Krumbholz A, Eitner A, Krieg R, Halbhuber KJ, Wutzler P (2007) Prevalence of PB1-F2 of influenza A viruses. J Gen Virol 88:536–546
Mazur I, Anhlan D, Mitzner D, Wixler L, Schubert U, Ludwig S (2008) The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol 10:1140–1152
Zamarin D, Ortigoza MB, Palese P (2006) Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol 80:7976–7983
Iverson AR, Boyd KL, McAuley JL, Plano LR, Hart ME, McCullers JA (2011) Influenza virus primes mice for pneumonia from Staphylococcus aureus. J Infect Dis 203:880–888
Dudek SE, Wixler L, Nordhoff C, Nordmann A, Anhlan D, Wixler V, Ludwig S (2011) The influenza virus PB1-F2 protein has interferon antagonistic activity. Biol Chem 392:1135–1144
Le Goffic R, Bouguyon E, Chevalier C, Vidic J, Da Costa B, Leymarie O, Bourdieu C, Decamps L, Dhorne-Pollet S, Delmas B (2010) Influenza A virus protein PB1-F2 exacerbates IFN-beta expression of human respiratory epithelial cells. J Immunol 185:4812–4823
McAuley JL, Chipuk JE, Boyd KL, Van De Velde N, Green DR, McCullers JA (2010) PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog 6:e1001014
James J, Howard W, Iqbal M, Nair VK, Barclay WS, Shelton H (2016) Influenza A virus PB1-F2 protein prolongs viral shedding in chickens lengthening the transmission window. J Gen Virol 97:2516–2527
Leymarie O, Embury-Hyatt C, Chevalier C, Jouneau L, Moroldo M, Da Costa B, Berhane Y, Delmas B, Weingartl HM, Le Goffic R (2014) PB1-F2 attenuates virulence of highly pathogenic avian H5N1 influenza virus in chickens. PLoS One 9:e100679
Schmolke M, Manicassamy B, Pena L, Sutton T, Hai R, Varga ZT, Hale BG, Steel J, Perez DR, Garcia-Sastre A (2011) Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species. PLoS Pathog 7:e1002186
Mettier J, Marc D, Sedano L, Da Costa B, Chevalier C, Le Goffic R (2021) Study of the host specificity of PB1-F2-associated virulence. Virulence 12:1647–1660
Choi JW, Shin EK, Ha SH, Kim HA, Kim YH, Kim JS, Hahn TW (2007) Optimal conditions for cryopreservation of primary chicken embryo kidney cells with dimethyl sulfoxide. Mol Biotechnol 35:237–241
Dietze K, Graaf A, Homeier-Bachmann T, Grund C, Forth L, Pohlmann A, Jeske C, Wintermann M, Beer M, Conraths FJ, Harder T (2018) From low to high pathogenicity-characterization of H7N7 avian influenza viruses in two epidemiologically linked outbreaks. Transbound Emerg Dis 65:1576–1587
Scheibner D, Ulrich R, Fatola OI, Graaf A, Gischke M, Salaheldin AH, Harder TC, Veits J, Mettenleiter TC, Abdelwhab EM (2019) Variable impact of the hemagglutinin polybasic cleavage site on virulence and pathogenesis of avian influenza H7N7 virus in chickens, turkeys and ducks. Sci Rep 9:11556
Stech J, Stech O, Herwig A, Altmeppen H, Hundt J, Gohrbandt S, Kreibich A, Weber S, Klenk HD, Mettenleiter TC (2008) Rapid and reliable universal cloning of influenza A virus genes by target-primed plasmid amplification. Nucleic Acids Res 36:e139
Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG (2000) A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 97:6108–6113
Mostafa A, Blaurock C, Scheibner D, Muller C, Blohm U, Schafer A, Gischke M, Salaheldin AH, Nooh HZ, Ali MA, Breithaupt A, Mettenleiter TC, Pleschka S, Abdelwhab EM (2020) Genetic incompatibilities and reduced transmission in chickens may limit the evolution of reassortants between H9N2 and panzootic H5N8 clade 2344 avian influenza virus showing high virulence for mammals. Virus Evol 6:veaa077
Henritzi D, Hoffmann B, Wacheck S, Pesch S, Herrler G, Beer M, Harder TC (2019) A newly developed tetraplex real-time RT-PCR for simultaneous screening of influenza virus types A, B, C and D. Influenza Other Respir Viruses 13:71–82
Graaf A, Ulrich R, Maksimov P, Scheibner D, Koethe S, Abdelwhab EM, Mettenleiter TC, Beer M, Harder T (2018) A viral race for primacy: co-infection of a natural pair of low and highly pathogenic H7N7 avian influenza viruses in chickens and embryonated chicken eggs. Emerg Microbes Infect 7:204
Chang P, Kuchipudi SV, Mellits KH, Sebastian S, James J, Liu J, Shelton H, Chang KC (2015) Early apoptosis of porcine alveolar macrophages limits avian influenza virus replication and pro-inflammatory dysregulation. Sci Rep 5:17999
Bonneville M, O’Brien RL, Born WK (2010) Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol 10:467–478
McAuley JL, Zhang K, McCullers JA (2010) The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis. J Virol 84:558–564
Chen CJ, Chen GW, Wang CH, Huang CH, Wang YC, Shih SR (2010) Differential localization and function of PB1-F2 derived from different strains of influenza A virus. J Virol 84:10051–10062
Meunier I, von Messling V (2012) PB1-F2 modulates early host responses but does not affect the pathogenesis of H1N1 seasonal influenza virus. J Virol 86:4271–4278
Alymova IV, York IA, McCullers JA (2014) Non-avian animal reservoirs present a source of influenza A PB1-F2 proteins with novel virulence-enhancing markers. PLoS One 9:e111603
Zmasek CM, Godzik A (2013) Evolution of the animal apoptosis network. Cold Spring Harb Perspect Biol 5:a008649
Deventhiran J, Kumar SR, Raghunath S, Leroith T, Elankumaran S (2016) PB1-F2 protein does not impact the virulence of triple-reassortant H3N2 swine influenza virus in pigs but alters pathogenicity and transmission in turkeys. J Virol 90:222–231
Starick E, Fereidouni SR, Lange E, Grund C, Vahlenkamp T, Beer M, Harder TC (2011) Analysis of influenza A viruses of subtype H1 from wild birds, turkeys and pigs in Germany reveals interspecies transmission events. Influenza Other Respir Viruses 5:276–284
Health EPoA, Welfare, More S, Bicout D, Botner A, Butterworth A, Calistri P, Depner K, Edwards S, Garin-Bastuji B, Good M, Gortazar Schmidt C, Michel V, Miranda MA, Nielsen SS, Raj M, Sihvonen L, Spoolder H, Thulke HH, Velarde A, Willeberg P, Winckler C, Breed A, Brouwer A, Guillemain M, Harder T, Monne I, Roberts H, Baldinelli F, Barrucci F et al. (2017) Avian influenza. EFSA J 15:e04991
Naguib MM, Verhagen JH, Mostafa A, Wille M, Li R, Graaf A, Jarhult JD, Ellstrom P, Zohari S, Lundkvist A, Olsen B (2019) Global patterns of avian influenza A (H7): virus evolution and zoonotic threats. FEMS Microbiol Rev 43:608–621
Caliendo V, Leijten L, Begeman L, Poen MJ, Fouchier RAM, Beerens N, Kuiken T (2020) Enterotropism of highly pathogenic avian influenza virus H5N8 from the 2016/2017 epidemic in some wild bird species. Vet Res 51:117
Gotur SP, Wadhwan V (2020) Tingible body macrophages. J Oral Maxillofac Pathol 24:418–420
Elmore SA (2006) Enhanced histopathology of the thymus. Toxicol Pathol 34:656–665
Xu G, Shi Y (2007) Apoptosis signaling pathways and lymphocyte homeostasis. Cell Res 17:759–771
McAuley JL, Hornung F, Boyd KL, Smith AM, McKeon R, Bennink J, Yewdell JW, McCullers JA (2007) Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2:240–249
Leymarie O, Jouvion G, Herve PL, Chevalier C, Lorin V, Lecardonnel J, Da Costa B, Delmas B, Escriou N, Le Goffic R (2013) Kinetic characterization of PB1-F2-mediated immunopathology during highly pathogenic avian H5N1 influenza virus infection. PLoS One 8:e57894
Sabbaghi A, Miri SM, Keshavarz M, Mahooti M, Zebardast A, Ghaemi A (2020) Role of gammadelta T cells in controlling viral infections with a focus on influenza virus: implications for designing novel therapeutic approaches. Virol J 17:174
Laursen AMS, Kulkarni RR, Taha-Abdelaziz K, Plattner BL, Read LR, Sharif S (2018) Characterizaton of gamma delta T cells in Marek’s disease virus (Gallid herpesvirus 2) infection of chickens. Virology 522:56–64
Fenzl L, Gobel TW, Neulen ML (2017) gammadelta T cells represent a major spontaneously cytotoxic cell population in the chicken. Dev Comp Immunol 73:175–183
Quere P, Cooper MD, Thorbecke GJ (1990) Characterization of suppressor T cells for antibody production by chicken spleen cells. I. Antigen-induced suppressor cells are CT8+, TcR1+ (gamma delta) T cells. Immunology 71:517–522
Acknowledgements
The authors thank Stefanie Knöfel, Dajana Helke and Robin Brandt for laboratory technical assistance. For animal caretaking we thank Frank Klipp, Doreen Fiedler, Nicole Sinkwitz and Kerstin Kerstel. We are grateful to Karsten Knop for incubating the chicken eggs. Lastly, we want to thank Maryna Kuryshko and Diana Palme for their help conducting the animal experiments.
Funding
Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Contributions
Study conception: UB, TCM, AD, EMA, HS. Data collection: LH, AB, DS, AS, EMA. Data analysis and interpretation: LH, UB, AB, EMA, AD. Drafting the article: LH, UB. Critical revision of the article: UB, EMA, AB, AD, AS, TCM. HS. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing interests.
Additional information
Handling editor: Marie Galloux.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Additional file 1: Dose finding studies for phenotyping of DF-1 cells
. Confluent DF-1 cells were infected at different MOI (0.1, 0.01, 0.001) and subsequently collected and stained for flow cytometrical analysis. A. After Life-dead staining with Zombie Aqua single, living cells were selected. Statistical analysis was done as two-way ANOVA with Tukey’s multiple comparison test. B. Living cells were further characterized with a monoclonal NP antibody. Statistical analyses were performed using two-way ANOVA with Šídák’s multiple comparisons test.
Additional file 2: Representative Gating strategy for in vitro flow cytometrical phenotyping.
Analyses were performed on pre-gated singlets. After selecting the relevant cell population (SSC/FSC) Zombie-negative NP + (infected) or Zombie-negative NP-negative (naïve control) were tested for their aCas3 expression.
Additional file 3: Protein sequence of AR1385 PB1-F2.
Highlighted in red is the insertion sight for the introduced mutation in ΔF2. The positions were cytotoxic motifs were previously published are marked grey, the motifs published by Alymova et al. [42] are supplied beneath. For detailed information fasta files are provided (Additional files 4 and 5).
Additional file 4.
FASTA file H7N7 AR 1385_15 wt PB1-F2.
Additional file 5.
FASTA file H7N7 AR 1385_15 delta F2 PB1-F2.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Hohensee, L., Scheibner, D., Schäfer, A. et al. The role of PB1-F2 in adaptation of high pathogenicity avian influenza virus H7N7 in chickens. Vet Res 55, 5 (2024). https://doi.org/10.1186/s13567-023-01257-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13567-023-01257-8